Global Breast Lesion Localization Methods research

Breast Lesion Localization Methods Comprehensive Study by Type (Wire, Radioisotope, Electromagnetic, Magnetic, Other), Application (Women, Men), End-Users (Diagnostic Centers, Hospitals, Ambulatory Surgical Centers, Oncology Centers) Players and Region - Global Market Outlook to 2028

Breast Lesion Localization Methods Market by XX Submarkets | Forecast Years 2023-2028 | CAGR: 11.2%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
Developments in diagnostic breast imaging have led to the prior detection of breast cancer as well as rise in the diagnosis of lesions requiring excisional biopsy. The removal of these small breast lesions needs a localization device to confirm the accurate removal of the target tissue. The primary method of breast lesion localization to guide excision was preoperative placement of a hook wire. However, due to the problems and inefficiencies of wire placement, there has been a recent surge in innovation in the area of breast localization such as Radioisotope, Electromagnetic and Magnetic. According to AMA Research, the market for Breast Lesion Localization Methods is expected to register a CAGR of 11.2% during the forecast period to 2028. This growth is primarily driven by Increasing Number of Breast Cancer Surgeries .

AttributesDetails
Study Period2018-2028
Base Year2022
Forecast Period2024-2028
Volume UnitN
Value UnitUSD (Million)
Customization ScopeAvail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility


The Health Care Services sector in the region has been increasing at a sustainable rate and further growth is expected to be witnessed over the forecast period, owing to the robust investments and expansion in production facilities in the region. Major Players, such as C.R. Bard (United States), SOMATEX Medical Technologies GmbH (Germany), Argon Medical Devices, Inc. (United States), Cianna Medical, Inc. (United States), Cook Medical (United States), Ranfac Corporation (Germany), C.P. Medical (United States), B.D. Company (United States), Endomagnetics Ltd (United Kingdom), Health Beacon (Ireland) and Leica Biosystems (Germany), etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.

Key Developments in the Market:
On 1st April 2021, Hologic, Inc., an innovative medical technology company primarily focused on improving women’s health, announced it has completed the acquisition of SOMATEX Medical Technologies GmbH, a leader in biopsy site markers and localization technologies, for approximately USD64 million. The company was previously owned by E-Med Solutions GmbH, Berlin, a group of investors led by German private equity company Westlake Partners.
The companies are exploring the market by adopting expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail competitive advantage through combined synergies.

Regulatory Insights:
SDOs are instructions, orders, rules, regulations, or procedures that specify what actions should be taken under what sets of conditions and circumstances. The SDOs define the conditions and circumstances under which an RN, LVN, or non-licensed healthcare provider (NLHP) actions or tasks may be initiated in the clinical setting, and they provide authority for use with individuals when a physician or advanced practice provider is not present, and/or before being examined or evaluated by a physician or advanced practice provider.

Influencing Trend:
Rising Awareness Level about Breast Cancer

Market Growth Drivers:
Increasing Number of Breast Cancer Surgeries and Rising Incidence of Breast Cancer

Challenges:
High Re-Excision Rates

Restraints:
Risks Associated With the Use of Devices

Opportunities:
Rising Investment for Better Healthcare Infrastructure and Increasing Adoption of Technology

AMA Research follows a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mainly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcases the spontaneously changing Players landscape impacting the market's growth. Furthermore, our market researchers extensively analyze the products and services offered by multiple players competing to increase their market share and presence.

Data Sources of Breast Lesion Localization Methods Market Study

Primary Collection: InMail, LinkedIn Groups, Survey Monkey, Google, and Other professional Forums are some of the mediums utilized to gather primary data through key industry participants and appointees, subject-matter experts, C-level executives of Breast Lesion Localization Methods Industry, among others including independent industry consultants, experts, to obtain and verify critical qualitative commentary and opinion and quantitative statistics, to assess future market prospects.

The primary interviews and data collected as per the below protocols:
• By Designation: C-Level, D-Level, Others
• By Company Type: Tier 1, Tier 2, Tier 3

Secondary Data Sources such as Annual reports, Press releases, Analyst meetings, Conference calls, Investor presentations, Management statements, and SEC filings of Breast Lesion Localization Methods players along with Regulatory Sites, Association, World bank, etc were used as sources secondary set of data.

Customization in the Report
AMA Research features not only specific market forecasts but also includes significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis

Against this Challenging Backdrop, Breast Lesion Localization Methods Study Sheds Light on
— The Breast Lesion Localization Methods Market status quo and key characteristics. To end this, Analysts at AMA organize and took surveys of the Breast Lesion Localization Methods industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Breast Lesion Localization Methods industry is heading and what are the top priorities. Insights are drawn from financial analysis, surveys, and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold the value they currently claim or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Type
  • Wire
  • Radioisotope
  • Electromagnetic
  • Magnetic
  • Other
By Application
  • Women
  • Men
By End-Users
  • Diagnostic Centers
  • Hospitals
  • Ambulatory Surgical Centers
  • Oncology Centers

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Number of Breast Cancer Surgeries
      • 3.2.2. Rising Incidence of Breast Cancer
    • 3.3. Market Challenges
      • 3.3.1. High Re-Excision Rates
    • 3.4. Market Trends
      • 3.4.1. Rising Awareness Level about Breast Cancer
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Breast Lesion Localization Methods, by Type, Application, End-Users and Region (value and price ) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Breast Lesion Localization Methods (Value)
      • 5.2.1. Global Breast Lesion Localization Methods by: Type (Value)
        • 5.2.1.1. Wire
        • 5.2.1.2. Radioisotope
        • 5.2.1.3. Electromagnetic
        • 5.2.1.4. Magnetic
        • 5.2.1.5. Other
      • 5.2.2. Global Breast Lesion Localization Methods by: Application (Value)
        • 5.2.2.1. Women
        • 5.2.2.2. Men
      • 5.2.3. Global Breast Lesion Localization Methods by: End-Users (Value)
        • 5.2.3.1. Diagnostic Centers
        • 5.2.3.2. Hospitals
        • 5.2.3.3. Ambulatory Surgical Centers
        • 5.2.3.4. Oncology Centers
      • 5.2.4. Global Breast Lesion Localization Methods Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Breast Lesion Localization Methods (Price)
      • 5.3.1. Global Breast Lesion Localization Methods by: Type (Price)
  • 6. Breast Lesion Localization Methods: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. C.R. Bard (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. SOMATEX Medical Technologies GmbH (Germany)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Argon Medical Devices, Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Cianna Medical, Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Cook Medical (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Ranfac Corporation (Germany)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. C.P. Medical (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. B.D. Company (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Endomagnetics Ltd (United Kingdom)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Health Beacon (Ireland)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Leica Biosystems (Germany)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
  • 7. Global Breast Lesion Localization Methods Sale, by Type, Application, End-Users and Region (value and price ) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Breast Lesion Localization Methods (Value)
      • 7.2.1. Global Breast Lesion Localization Methods by: Type (Value)
        • 7.2.1.1. Wire
        • 7.2.1.2. Radioisotope
        • 7.2.1.3. Electromagnetic
        • 7.2.1.4. Magnetic
        • 7.2.1.5. Other
      • 7.2.2. Global Breast Lesion Localization Methods by: Application (Value)
        • 7.2.2.1. Women
        • 7.2.2.2. Men
      • 7.2.3. Global Breast Lesion Localization Methods by: End-Users (Value)
        • 7.2.3.1. Diagnostic Centers
        • 7.2.3.2. Hospitals
        • 7.2.3.3. Ambulatory Surgical Centers
        • 7.2.3.4. Oncology Centers
      • 7.2.4. Global Breast Lesion Localization Methods Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Breast Lesion Localization Methods (Price)
      • 7.3.1. Global Breast Lesion Localization Methods by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Breast Lesion Localization Methods: by Type(USD Million)
  • Table 2. Breast Lesion Localization Methods Wire , by Region USD Million (2017-2022)
  • Table 3. Breast Lesion Localization Methods Radioisotope , by Region USD Million (2017-2022)
  • Table 4. Breast Lesion Localization Methods Electromagnetic , by Region USD Million (2017-2022)
  • Table 5. Breast Lesion Localization Methods Magnetic , by Region USD Million (2017-2022)
  • Table 6. Breast Lesion Localization Methods Other , by Region USD Million (2017-2022)
  • Table 7. Breast Lesion Localization Methods: by Application(USD Million)
  • Table 8. Breast Lesion Localization Methods Women , by Region USD Million (2017-2022)
  • Table 9. Breast Lesion Localization Methods Men , by Region USD Million (2017-2022)
  • Table 10. Breast Lesion Localization Methods: by End-Users(USD Million)
  • Table 11. Breast Lesion Localization Methods Diagnostic Centers , by Region USD Million (2017-2022)
  • Table 12. Breast Lesion Localization Methods Hospitals , by Region USD Million (2017-2022)
  • Table 13. Breast Lesion Localization Methods Ambulatory Surgical Centers , by Region USD Million (2017-2022)
  • Table 14. Breast Lesion Localization Methods Oncology Centers , by Region USD Million (2017-2022)
  • Table 15. South America Breast Lesion Localization Methods, by Country USD Million (2017-2022)
  • Table 16. South America Breast Lesion Localization Methods, by Type USD Million (2017-2022)
  • Table 17. South America Breast Lesion Localization Methods, by Application USD Million (2017-2022)
  • Table 18. South America Breast Lesion Localization Methods, by End-Users USD Million (2017-2022)
  • Table 19. Brazil Breast Lesion Localization Methods, by Type USD Million (2017-2022)
  • Table 20. Brazil Breast Lesion Localization Methods, by Application USD Million (2017-2022)
  • Table 21. Brazil Breast Lesion Localization Methods, by End-Users USD Million (2017-2022)
  • Table 22. Argentina Breast Lesion Localization Methods, by Type USD Million (2017-2022)
  • Table 23. Argentina Breast Lesion Localization Methods, by Application USD Million (2017-2022)
  • Table 24. Argentina Breast Lesion Localization Methods, by End-Users USD Million (2017-2022)
  • Table 25. Rest of South America Breast Lesion Localization Methods, by Type USD Million (2017-2022)
  • Table 26. Rest of South America Breast Lesion Localization Methods, by Application USD Million (2017-2022)
  • Table 27. Rest of South America Breast Lesion Localization Methods, by End-Users USD Million (2017-2022)
  • Table 28. Asia Pacific Breast Lesion Localization Methods, by Country USD Million (2017-2022)
  • Table 29. Asia Pacific Breast Lesion Localization Methods, by Type USD Million (2017-2022)
  • Table 30. Asia Pacific Breast Lesion Localization Methods, by Application USD Million (2017-2022)
  • Table 31. Asia Pacific Breast Lesion Localization Methods, by End-Users USD Million (2017-2022)
  • Table 32. China Breast Lesion Localization Methods, by Type USD Million (2017-2022)
  • Table 33. China Breast Lesion Localization Methods, by Application USD Million (2017-2022)
  • Table 34. China Breast Lesion Localization Methods, by End-Users USD Million (2017-2022)
  • Table 35. Japan Breast Lesion Localization Methods, by Type USD Million (2017-2022)
  • Table 36. Japan Breast Lesion Localization Methods, by Application USD Million (2017-2022)
  • Table 37. Japan Breast Lesion Localization Methods, by End-Users USD Million (2017-2022)
  • Table 38. India Breast Lesion Localization Methods, by Type USD Million (2017-2022)
  • Table 39. India Breast Lesion Localization Methods, by Application USD Million (2017-2022)
  • Table 40. India Breast Lesion Localization Methods, by End-Users USD Million (2017-2022)
  • Table 41. South Korea Breast Lesion Localization Methods, by Type USD Million (2017-2022)
  • Table 42. South Korea Breast Lesion Localization Methods, by Application USD Million (2017-2022)
  • Table 43. South Korea Breast Lesion Localization Methods, by End-Users USD Million (2017-2022)
  • Table 44. Taiwan Breast Lesion Localization Methods, by Type USD Million (2017-2022)
  • Table 45. Taiwan Breast Lesion Localization Methods, by Application USD Million (2017-2022)
  • Table 46. Taiwan Breast Lesion Localization Methods, by End-Users USD Million (2017-2022)
  • Table 47. Australia Breast Lesion Localization Methods, by Type USD Million (2017-2022)
  • Table 48. Australia Breast Lesion Localization Methods, by Application USD Million (2017-2022)
  • Table 49. Australia Breast Lesion Localization Methods, by End-Users USD Million (2017-2022)
  • Table 50. Rest of Asia-Pacific Breast Lesion Localization Methods, by Type USD Million (2017-2022)
  • Table 51. Rest of Asia-Pacific Breast Lesion Localization Methods, by Application USD Million (2017-2022)
  • Table 52. Rest of Asia-Pacific Breast Lesion Localization Methods, by End-Users USD Million (2017-2022)
  • Table 53. Europe Breast Lesion Localization Methods, by Country USD Million (2017-2022)
  • Table 54. Europe Breast Lesion Localization Methods, by Type USD Million (2017-2022)
  • Table 55. Europe Breast Lesion Localization Methods, by Application USD Million (2017-2022)
  • Table 56. Europe Breast Lesion Localization Methods, by End-Users USD Million (2017-2022)
  • Table 57. Germany Breast Lesion Localization Methods, by Type USD Million (2017-2022)
  • Table 58. Germany Breast Lesion Localization Methods, by Application USD Million (2017-2022)
  • Table 59. Germany Breast Lesion Localization Methods, by End-Users USD Million (2017-2022)
  • Table 60. France Breast Lesion Localization Methods, by Type USD Million (2017-2022)
  • Table 61. France Breast Lesion Localization Methods, by Application USD Million (2017-2022)
  • Table 62. France Breast Lesion Localization Methods, by End-Users USD Million (2017-2022)
  • Table 63. Italy Breast Lesion Localization Methods, by Type USD Million (2017-2022)
  • Table 64. Italy Breast Lesion Localization Methods, by Application USD Million (2017-2022)
  • Table 65. Italy Breast Lesion Localization Methods, by End-Users USD Million (2017-2022)
  • Table 66. United Kingdom Breast Lesion Localization Methods, by Type USD Million (2017-2022)
  • Table 67. United Kingdom Breast Lesion Localization Methods, by Application USD Million (2017-2022)
  • Table 68. United Kingdom Breast Lesion Localization Methods, by End-Users USD Million (2017-2022)
  • Table 69. Netherlands Breast Lesion Localization Methods, by Type USD Million (2017-2022)
  • Table 70. Netherlands Breast Lesion Localization Methods, by Application USD Million (2017-2022)
  • Table 71. Netherlands Breast Lesion Localization Methods, by End-Users USD Million (2017-2022)
  • Table 72. Rest of Europe Breast Lesion Localization Methods, by Type USD Million (2017-2022)
  • Table 73. Rest of Europe Breast Lesion Localization Methods, by Application USD Million (2017-2022)
  • Table 74. Rest of Europe Breast Lesion Localization Methods, by End-Users USD Million (2017-2022)
  • Table 75. MEA Breast Lesion Localization Methods, by Country USD Million (2017-2022)
  • Table 76. MEA Breast Lesion Localization Methods, by Type USD Million (2017-2022)
  • Table 77. MEA Breast Lesion Localization Methods, by Application USD Million (2017-2022)
  • Table 78. MEA Breast Lesion Localization Methods, by End-Users USD Million (2017-2022)
  • Table 79. Middle East Breast Lesion Localization Methods, by Type USD Million (2017-2022)
  • Table 80. Middle East Breast Lesion Localization Methods, by Application USD Million (2017-2022)
  • Table 81. Middle East Breast Lesion Localization Methods, by End-Users USD Million (2017-2022)
  • Table 82. Africa Breast Lesion Localization Methods, by Type USD Million (2017-2022)
  • Table 83. Africa Breast Lesion Localization Methods, by Application USD Million (2017-2022)
  • Table 84. Africa Breast Lesion Localization Methods, by End-Users USD Million (2017-2022)
  • Table 85. North America Breast Lesion Localization Methods, by Country USD Million (2017-2022)
  • Table 86. North America Breast Lesion Localization Methods, by Type USD Million (2017-2022)
  • Table 87. North America Breast Lesion Localization Methods, by Application USD Million (2017-2022)
  • Table 88. North America Breast Lesion Localization Methods, by End-Users USD Million (2017-2022)
  • Table 89. United States Breast Lesion Localization Methods, by Type USD Million (2017-2022)
  • Table 90. United States Breast Lesion Localization Methods, by Application USD Million (2017-2022)
  • Table 91. United States Breast Lesion Localization Methods, by End-Users USD Million (2017-2022)
  • Table 92. Canada Breast Lesion Localization Methods, by Type USD Million (2017-2022)
  • Table 93. Canada Breast Lesion Localization Methods, by Application USD Million (2017-2022)
  • Table 94. Canada Breast Lesion Localization Methods, by End-Users USD Million (2017-2022)
  • Table 95. Mexico Breast Lesion Localization Methods, by Type USD Million (2017-2022)
  • Table 96. Mexico Breast Lesion Localization Methods, by Application USD Million (2017-2022)
  • Table 97. Mexico Breast Lesion Localization Methods, by End-Users USD Million (2017-2022)
  • Table 98. Breast Lesion Localization Methods: by Type(USD/Units)
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Company Basic Information, Sales Area and Its Competitors
  • Table 110. Breast Lesion Localization Methods: by Type(USD Million)
  • Table 111. Breast Lesion Localization Methods Wire , by Region USD Million (2023-2028)
  • Table 112. Breast Lesion Localization Methods Radioisotope , by Region USD Million (2023-2028)
  • Table 113. Breast Lesion Localization Methods Electromagnetic , by Region USD Million (2023-2028)
  • Table 114. Breast Lesion Localization Methods Magnetic , by Region USD Million (2023-2028)
  • Table 115. Breast Lesion Localization Methods Other , by Region USD Million (2023-2028)
  • Table 116. Breast Lesion Localization Methods: by Application(USD Million)
  • Table 117. Breast Lesion Localization Methods Women , by Region USD Million (2023-2028)
  • Table 118. Breast Lesion Localization Methods Men , by Region USD Million (2023-2028)
  • Table 119. Breast Lesion Localization Methods: by End-Users(USD Million)
  • Table 120. Breast Lesion Localization Methods Diagnostic Centers , by Region USD Million (2023-2028)
  • Table 121. Breast Lesion Localization Methods Hospitals , by Region USD Million (2023-2028)
  • Table 122. Breast Lesion Localization Methods Ambulatory Surgical Centers , by Region USD Million (2023-2028)
  • Table 123. Breast Lesion Localization Methods Oncology Centers , by Region USD Million (2023-2028)
  • Table 124. South America Breast Lesion Localization Methods, by Country USD Million (2023-2028)
  • Table 125. South America Breast Lesion Localization Methods, by Type USD Million (2023-2028)
  • Table 126. South America Breast Lesion Localization Methods, by Application USD Million (2023-2028)
  • Table 127. South America Breast Lesion Localization Methods, by End-Users USD Million (2023-2028)
  • Table 128. Brazil Breast Lesion Localization Methods, by Type USD Million (2023-2028)
  • Table 129. Brazil Breast Lesion Localization Methods, by Application USD Million (2023-2028)
  • Table 130. Brazil Breast Lesion Localization Methods, by End-Users USD Million (2023-2028)
  • Table 131. Argentina Breast Lesion Localization Methods, by Type USD Million (2023-2028)
  • Table 132. Argentina Breast Lesion Localization Methods, by Application USD Million (2023-2028)
  • Table 133. Argentina Breast Lesion Localization Methods, by End-Users USD Million (2023-2028)
  • Table 134. Rest of South America Breast Lesion Localization Methods, by Type USD Million (2023-2028)
  • Table 135. Rest of South America Breast Lesion Localization Methods, by Application USD Million (2023-2028)
  • Table 136. Rest of South America Breast Lesion Localization Methods, by End-Users USD Million (2023-2028)
  • Table 137. Asia Pacific Breast Lesion Localization Methods, by Country USD Million (2023-2028)
  • Table 138. Asia Pacific Breast Lesion Localization Methods, by Type USD Million (2023-2028)
  • Table 139. Asia Pacific Breast Lesion Localization Methods, by Application USD Million (2023-2028)
  • Table 140. Asia Pacific Breast Lesion Localization Methods, by End-Users USD Million (2023-2028)
  • Table 141. China Breast Lesion Localization Methods, by Type USD Million (2023-2028)
  • Table 142. China Breast Lesion Localization Methods, by Application USD Million (2023-2028)
  • Table 143. China Breast Lesion Localization Methods, by End-Users USD Million (2023-2028)
  • Table 144. Japan Breast Lesion Localization Methods, by Type USD Million (2023-2028)
  • Table 145. Japan Breast Lesion Localization Methods, by Application USD Million (2023-2028)
  • Table 146. Japan Breast Lesion Localization Methods, by End-Users USD Million (2023-2028)
  • Table 147. India Breast Lesion Localization Methods, by Type USD Million (2023-2028)
  • Table 148. India Breast Lesion Localization Methods, by Application USD Million (2023-2028)
  • Table 149. India Breast Lesion Localization Methods, by End-Users USD Million (2023-2028)
  • Table 150. South Korea Breast Lesion Localization Methods, by Type USD Million (2023-2028)
  • Table 151. South Korea Breast Lesion Localization Methods, by Application USD Million (2023-2028)
  • Table 152. South Korea Breast Lesion Localization Methods, by End-Users USD Million (2023-2028)
  • Table 153. Taiwan Breast Lesion Localization Methods, by Type USD Million (2023-2028)
  • Table 154. Taiwan Breast Lesion Localization Methods, by Application USD Million (2023-2028)
  • Table 155. Taiwan Breast Lesion Localization Methods, by End-Users USD Million (2023-2028)
  • Table 156. Australia Breast Lesion Localization Methods, by Type USD Million (2023-2028)
  • Table 157. Australia Breast Lesion Localization Methods, by Application USD Million (2023-2028)
  • Table 158. Australia Breast Lesion Localization Methods, by End-Users USD Million (2023-2028)
  • Table 159. Rest of Asia-Pacific Breast Lesion Localization Methods, by Type USD Million (2023-2028)
  • Table 160. Rest of Asia-Pacific Breast Lesion Localization Methods, by Application USD Million (2023-2028)
  • Table 161. Rest of Asia-Pacific Breast Lesion Localization Methods, by End-Users USD Million (2023-2028)
  • Table 162. Europe Breast Lesion Localization Methods, by Country USD Million (2023-2028)
  • Table 163. Europe Breast Lesion Localization Methods, by Type USD Million (2023-2028)
  • Table 164. Europe Breast Lesion Localization Methods, by Application USD Million (2023-2028)
  • Table 165. Europe Breast Lesion Localization Methods, by End-Users USD Million (2023-2028)
  • Table 166. Germany Breast Lesion Localization Methods, by Type USD Million (2023-2028)
  • Table 167. Germany Breast Lesion Localization Methods, by Application USD Million (2023-2028)
  • Table 168. Germany Breast Lesion Localization Methods, by End-Users USD Million (2023-2028)
  • Table 169. France Breast Lesion Localization Methods, by Type USD Million (2023-2028)
  • Table 170. France Breast Lesion Localization Methods, by Application USD Million (2023-2028)
  • Table 171. France Breast Lesion Localization Methods, by End-Users USD Million (2023-2028)
  • Table 172. Italy Breast Lesion Localization Methods, by Type USD Million (2023-2028)
  • Table 173. Italy Breast Lesion Localization Methods, by Application USD Million (2023-2028)
  • Table 174. Italy Breast Lesion Localization Methods, by End-Users USD Million (2023-2028)
  • Table 175. United Kingdom Breast Lesion Localization Methods, by Type USD Million (2023-2028)
  • Table 176. United Kingdom Breast Lesion Localization Methods, by Application USD Million (2023-2028)
  • Table 177. United Kingdom Breast Lesion Localization Methods, by End-Users USD Million (2023-2028)
  • Table 178. Netherlands Breast Lesion Localization Methods, by Type USD Million (2023-2028)
  • Table 179. Netherlands Breast Lesion Localization Methods, by Application USD Million (2023-2028)
  • Table 180. Netherlands Breast Lesion Localization Methods, by End-Users USD Million (2023-2028)
  • Table 181. Rest of Europe Breast Lesion Localization Methods, by Type USD Million (2023-2028)
  • Table 182. Rest of Europe Breast Lesion Localization Methods, by Application USD Million (2023-2028)
  • Table 183. Rest of Europe Breast Lesion Localization Methods, by End-Users USD Million (2023-2028)
  • Table 184. MEA Breast Lesion Localization Methods, by Country USD Million (2023-2028)
  • Table 185. MEA Breast Lesion Localization Methods, by Type USD Million (2023-2028)
  • Table 186. MEA Breast Lesion Localization Methods, by Application USD Million (2023-2028)
  • Table 187. MEA Breast Lesion Localization Methods, by End-Users USD Million (2023-2028)
  • Table 188. Middle East Breast Lesion Localization Methods, by Type USD Million (2023-2028)
  • Table 189. Middle East Breast Lesion Localization Methods, by Application USD Million (2023-2028)
  • Table 190. Middle East Breast Lesion Localization Methods, by End-Users USD Million (2023-2028)
  • Table 191. Africa Breast Lesion Localization Methods, by Type USD Million (2023-2028)
  • Table 192. Africa Breast Lesion Localization Methods, by Application USD Million (2023-2028)
  • Table 193. Africa Breast Lesion Localization Methods, by End-Users USD Million (2023-2028)
  • Table 194. North America Breast Lesion Localization Methods, by Country USD Million (2023-2028)
  • Table 195. North America Breast Lesion Localization Methods, by Type USD Million (2023-2028)
  • Table 196. North America Breast Lesion Localization Methods, by Application USD Million (2023-2028)
  • Table 197. North America Breast Lesion Localization Methods, by End-Users USD Million (2023-2028)
  • Table 198. United States Breast Lesion Localization Methods, by Type USD Million (2023-2028)
  • Table 199. United States Breast Lesion Localization Methods, by Application USD Million (2023-2028)
  • Table 200. United States Breast Lesion Localization Methods, by End-Users USD Million (2023-2028)
  • Table 201. Canada Breast Lesion Localization Methods, by Type USD Million (2023-2028)
  • Table 202. Canada Breast Lesion Localization Methods, by Application USD Million (2023-2028)
  • Table 203. Canada Breast Lesion Localization Methods, by End-Users USD Million (2023-2028)
  • Table 204. Mexico Breast Lesion Localization Methods, by Type USD Million (2023-2028)
  • Table 205. Mexico Breast Lesion Localization Methods, by Application USD Million (2023-2028)
  • Table 206. Mexico Breast Lesion Localization Methods, by End-Users USD Million (2023-2028)
  • Table 207. Breast Lesion Localization Methods: by Type(USD/Units)
  • Table 208. Research Programs/Design for This Report
  • Table 209. Key Data Information from Secondary Sources
  • Table 210. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Breast Lesion Localization Methods: by Type USD Million (2017-2022)
  • Figure 5. Global Breast Lesion Localization Methods: by Application USD Million (2017-2022)
  • Figure 6. Global Breast Lesion Localization Methods: by End-Users USD Million (2017-2022)
  • Figure 7. South America Breast Lesion Localization Methods Share (%), by Country
  • Figure 8. Asia Pacific Breast Lesion Localization Methods Share (%), by Country
  • Figure 9. Europe Breast Lesion Localization Methods Share (%), by Country
  • Figure 10. MEA Breast Lesion Localization Methods Share (%), by Country
  • Figure 11. North America Breast Lesion Localization Methods Share (%), by Country
  • Figure 12. Global Breast Lesion Localization Methods: by Type USD/Units (2017-2022)
  • Figure 13. Global Breast Lesion Localization Methods share by Players 2022 (%)
  • Figure 14. Global Breast Lesion Localization Methods share by Players (Top 3) 2022(%)
  • Figure 15. Global Breast Lesion Localization Methods share by Players (Top 5) 2022(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. C.R. Bard (United States) Revenue, Net Income and Gross profit
  • Figure 18. C.R. Bard (United States) Revenue: by Geography 2022
  • Figure 19. SOMATEX Medical Technologies GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 20. SOMATEX Medical Technologies GmbH (Germany) Revenue: by Geography 2022
  • Figure 21. Argon Medical Devices, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 22. Argon Medical Devices, Inc. (United States) Revenue: by Geography 2022
  • Figure 23. Cianna Medical, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 24. Cianna Medical, Inc. (United States) Revenue: by Geography 2022
  • Figure 25. Cook Medical (United States) Revenue, Net Income and Gross profit
  • Figure 26. Cook Medical (United States) Revenue: by Geography 2022
  • Figure 27. Ranfac Corporation (Germany) Revenue, Net Income and Gross profit
  • Figure 28. Ranfac Corporation (Germany) Revenue: by Geography 2022
  • Figure 29. C.P. Medical (United States) Revenue, Net Income and Gross profit
  • Figure 30. C.P. Medical (United States) Revenue: by Geography 2022
  • Figure 31. B.D. Company (United States) Revenue, Net Income and Gross profit
  • Figure 32. B.D. Company (United States) Revenue: by Geography 2022
  • Figure 33. Endomagnetics Ltd (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 34. Endomagnetics Ltd (United Kingdom) Revenue: by Geography 2022
  • Figure 35. Health Beacon (Ireland) Revenue, Net Income and Gross profit
  • Figure 36. Health Beacon (Ireland) Revenue: by Geography 2022
  • Figure 37. Leica Biosystems (Germany) Revenue, Net Income and Gross profit
  • Figure 38. Leica Biosystems (Germany) Revenue: by Geography 2022
  • Figure 39. Global Breast Lesion Localization Methods: by Type USD Million (2023-2028)
  • Figure 40. Global Breast Lesion Localization Methods: by Application USD Million (2023-2028)
  • Figure 41. Global Breast Lesion Localization Methods: by End-Users USD Million (2023-2028)
  • Figure 42. South America Breast Lesion Localization Methods Share (%), by Country
  • Figure 43. Asia Pacific Breast Lesion Localization Methods Share (%), by Country
  • Figure 44. Europe Breast Lesion Localization Methods Share (%), by Country
  • Figure 45. MEA Breast Lesion Localization Methods Share (%), by Country
  • Figure 46. North America Breast Lesion Localization Methods Share (%), by Country
  • Figure 47. Global Breast Lesion Localization Methods: by Type USD/Units (2023-2028)
List of companies from research coverage that are profiled in the study
  • C.R. Bard (United States)
  • SOMATEX Medical Technologies GmbH (Germany)
  • Argon Medical Devices, Inc. (United States)
  • Cianna Medical, Inc. (United States)
  • Cook Medical (United States)
  • Ranfac Corporation (Germany)
  • C.P. Medical (United States)
  • B.D. Company (United States)
  • Endomagnetics Ltd (United Kingdom)
  • Health Beacon (Ireland)
  • Leica Biosystems (Germany)
Select User Access Type

Key Highlights of Report


Jan 2024 178 Pages 57 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Breast Lesion Localization Methods research Quantitative research analysis
Global Breast Lesion Localization Methods research Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Historical year: 2018-2022; Base year: 2022; Forecast period: 2024 to 2028
Companies that are profiled in Global Breast Lesion Localization Methods Market are C.R. Bard (United States), SOMATEX Medical Technologies GmbH (Germany), Argon Medical Devices, Inc. (United States), Cianna Medical, Inc. (United States), Cook Medical (United States), Ranfac Corporation (Germany), C.P. Medical (United States), B.D. Company (United States), Endomagnetics Ltd (United Kingdom), Health Beacon (Ireland) and Leica Biosystems (Germany) etc.
Women segment in Global market to hold robust market share owing to "Increasing Number of Breast Cancer Surgeries ".
AMA Research predicts that German and United States Players will contribute to the maximum growth of Global Breast Lesion Localization Methods market throughout the forecasted period.

Know More About Global Breast Lesion Localization Methods research Report?

Have a Query? Click Here

Other Related Reports

Microbial Identification Service Comprehensive Study by Type (Instruments {Automated Microbial Identification Systems,.Mass Spectrometers, PCR, Microarrays, High-power Microscopes, Polystainers, Flow...
$ 3750
Ultrasonic Toothbrush Comprehensive Study by Type (Single Frequency, Dual Frequency), Application (Therapeutic Medical Devices, Household, Others), Components (Circuit, Motor, Switch, Cam and gears, ...
$ 3450
Veterinary Reference Laboratory Comprehensive Study by Type (Clinical Chemistry Services, Immunodiagnostic Services, Hematology Services, Urinalysis Services, Molecular Diagnostic Services, Other (Mi...
$ 3750
Venipuncture Procedure Comprehensive Study by Type (Median Cubital Vein, Cephalic Vein, Basilic Vein, Others), Application (Hospitals, Diagnostic Laboratories, Physician Offices/Clinics, Others), Equ...
$ 3350
Orthopedic Extremity Comprehensive Study by Type (Lower extremity, Upper extremity, Arthroscopic, Spine orthopedic, Orthobiologics, Braces & support), Application (Hip, Knee, Spine, Others), End User...
$ 3450
Skin Replacement Comprehensive Study by Type (Allograft, Autograft, Xenograft, Synthetic, Alloplastic), Application (Chemical, Cosmetic, Pharmaceutical), Material Type (Natural Skin, Synthetic Skin),...
$ 3800